A detailed history of Natixis Advisors, L.P. transactions in Option Care Health, Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 88,751 shares of OPCH stock, worth $2.05 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
88,751
Previous 81,222 9.27%
Holding current value
$2.05 Million
Previous $2.25 Million 23.47%
% of portfolio
0.01%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$26.73 - $32.74 $201,250 - $246,499
7,529 Added 9.27%
88,751 $2.78 Million
Q2 2024

Aug 01, 2024

SELL
$27.7 - $32.79 $150,771 - $178,475
-5,443 Reduced 6.28%
81,222 $2.25 Million
Q1 2024

Apr 25, 2024

BUY
$31.09 - $34.31 $192,260 - $212,173
6,184 Added 7.68%
86,665 $2.91 Million
Q4 2023

Feb 06, 2024

SELL
$26.63 - $34.02 $1.4 Million - $1.79 Million
-52,599 Reduced 39.52%
80,481 $2.71 Million
Q3 2023

Nov 13, 2023

BUY
$30.66 - $35.45 $1.56 Million - $1.8 Million
50,814 Added 61.77%
133,080 $4.31 Million
Q2 2023

Aug 15, 2023

BUY
$26.84 - $32.79 $236,138 - $288,486
8,798 Added 11.98%
82,266 $2.67 Million
Q1 2023

May 11, 2023

BUY
$27.68 - $33.17 $414,286 - $496,455
14,967 Added 25.58%
73,468 $2.33 Million
Q4 2022

Jan 27, 2023

BUY
$27.84 - $35.0 $253,705 - $318,955
9,113 Added 18.45%
58,501 $1.76 Million
Q3 2022

Nov 14, 2022

BUY
$28.39 - $35.14 $633,806 - $784,500
22,325 Added 82.49%
49,388 $1.55 Million
Q2 2022

Aug 12, 2022

BUY
$25.99 - $30.94 $360,689 - $429,385
13,878 Added 105.26%
27,063 $752,000
Q1 2022

May 12, 2022

SELL
$22.05 - $28.67 $3,792 - $4,931
-172 Reduced 1.29%
13,185 $377,000
Q4 2021

Feb 08, 2022

BUY
$23.72 - $28.44 $316,828 - $379,873
13,357 New
13,357 $380,000

Others Institutions Holding OPCH

About Option Care Health, Inc.


  • Ticker OPCH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 181,900,992
  • Market Cap $4.21B
  • Description
  • Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal dis...
More about OPCH
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.